Diagnostic utility of hepatitis C virus core antigen in hemodialysis patients

被引:23
作者
Medhi, Subhash [1 ,2 ,3 ]
Potukuchi, Sai K. [1 ,2 ]
Polipalli, Sunil K. [1 ,2 ]
Swargiary, Shyam S. [1 ,2 ,3 ]
Deka, Purabi [2 ]
Choudhary, Anish [1 ,4 ]
BegUin, Nargis [1 ,2 ,4 ]
Hussain, Zahid [1 ,2 ,4 ]
Ahlawat, R. S. [1 ,2 ]
Kar, Premashis [1 ,2 ]
机构
[1] Maulana Azad Med Coll, Dept Med, PCR Hepatitis Lab, New Delhi 110002, India
[2] Maulana Azad Med Coll, Lok Nayak Hosp, New Delhi 110002, India
[3] Gauhati Univ, Dept Biotechnol, Gauhati 781014, Assam, India
[4] Jamia Millia Islamia, Dept Biosci, Human Genet Lab, New Delhi 110025, India
关键词
HCV; hepatitis C virus; biomembranes; HCVcAg; HCV core antigen; RT-PCR; reverse transcriptase polymerase chain reaction; hemodialysis;
D O I
10.1016/j.clinbiochem.2007.12.024
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Patients undergoing hemodialysis are at high risk for Hepatitis C virus infection. Anti-HCV antibody detection is widely used for screening this infection but is not sensitive for window period detection. An ELISA to detect the HCV Core Antigen has recently become available. Objectives: To investigate the utility of the HCV core Antigen ELISA in the detection of HCV infection in hemodialysis patients and to compare with 3rd generation ELISA validated by real-time PCR. Methods: Two hundred fifty hemodialysis patients were included in the study. Anti-HCV antibodies and Total HCVcAg was determined by third generation ELISA kits. HCV RNA was determined using Reverse Transcriptase Polymerase Chain Reaction (RT-PCR) and sensitivity of the two assays was confirmed by estimating viral load using real-time PCR. Results: Forty-three out of 250 (17.2%) patients were positive for anti-HCV antibodies and HCVcAg. 13/250 (5.2%) were positive for HCVcAg but anti-HCV negative, which is statistically significant (P<0.05). All 13 were confirmed viremic by in-house nested RT-PCR leading to specificity of 100%. Viral load of 49,258 28,682 copies/mL were detected in HCVcAg positive cases in comparison to 239,383 107,805 copies/mL in the only anti-HCV positive group (P<0.001). False negative cases for HCVcAg assay accounted for 2/250 (0.8%) in which the viral load was 306 461 copies/mL which was significantly lower in comparison to HCVcAg positive group (P<0.001, t-test-9.982). Conclusions: Total HCVcAg ELISA is an accurate serological marker for early identification of HCV infection, than is possible by currently used serological assay. It will be useful for patients undergoing hemodialysis who have a longer window period due to immunosuppressed state. It is both a cost-effective and a less labor-intensive alternative to PCR, enhancing its clinical utility. (c) 2008 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:447 / 452
页数:6
相关论文
共 39 条
  • [21] Quantitation of HCV RNA using real-time PCR and fluorimetry
    Komurian-Pradel, F
    Paranhos-Baccalà, G
    Sodoyer, M
    Chevallier, P
    Mandrand, B
    Lotteau, V
    André, P
    [J]. JOURNAL OF VIROLOGICAL METHODS, 2001, 95 (1-2) : 111 - 119
  • [22] Krajden M, 2000, CAN J PUBLIC HEALTH, V91, pS34
  • [23] Medical progress: Hepatitis C virus infection.
    Lauer, GM
    Walker, BD
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (01) : 41 - 52
  • [24] Leone N, 2005, Minerva Gastroenterol Dietol, V51, P31
  • [25] ANTIBODY-RESPONSE TO CORE, ENVELOPE AND NONSTRUCTURAL HEPATITIS-C VIRUS-ANTIGENS - COMPARISON OF IMMUNOCOMPETENT AND IMMUNOSUPPRESSED PATIENTS
    LOK, ASF
    CHIEN, D
    CHOO, QL
    CHAN, TM
    CHIU, EKW
    CHENG, IKP
    HOUGHTON, M
    KUO, G
    [J]. HEPATOLOGY, 1993, 18 (03) : 497 - 502
  • [26] Antiviral effect of ribavirin in early non-responders to interferon monotherapy assessed by kinetics of hepatitis C virus RNA and hepatitis C virus core antigen
    Lunel, F
    Veillon, P
    Fouchard-Hubert, I
    Loustaud-Ratti, V
    Abergel, A
    Silvain, C
    Rifflet, H
    Blanchi, A
    Causse, X
    Bacq, Y
    Payan, C
    [J]. JOURNAL OF HEPATOLOGY, 2003, 39 (05) : 826 - 833
  • [27] Clinical relevance of total HCV Core antigen testing for hepatitis C monitoring and for predicting patients' response to therapy
    Maynard, M
    Pradat, P
    Berthillon, P
    Picchio, G
    Voirin, N
    Martinot, M
    Marcellin, P
    Trepo, C
    [J]. JOURNAL OF VIRAL HEPATITIS, 2003, 10 (04) : 318 - 323
  • [28] McCullough J, 2000, TRANSFUSION, V40, P143
  • [29] Is hepatitis C more aggressive in renal transplant patients than in patients with end-stage renal disease?
    Perez, Renata M.
    Ferreira, Adalgisa S. P.
    Medina-Pestana, Jose O.
    Cendoroglo-Neto, Miguel
    Lanzoni, Valeria P.
    Silva, Antonio Eduardo B.
    Ferraz, Maria Lucia G.
    [J]. JOURNAL OF CLINICAL GASTROENTEROLOGY, 2006, 40 (05) : 444 - 448
  • [30] Is alanine aminotransferase a good marker of histologic hepatic damage in renal transplant patients with hepatitis C virus infection?
    Perez, RM
    Ferreira, ASP
    Medina-Pestana, JO
    Lanzoni, VP
    Silva, AEB
    Ferraz, MLG
    [J]. CLINICAL TRANSPLANTATION, 2005, 19 (05) : 622 - 625